Darja Fercej-Temeljotov

Title: The Innovative Contributions of Darja Fercej-Temeljotov

Introduction

Darja Fercej-Temeljotov is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel inclusion complexes. With a total of 4 patents to his name, his work has had a considerable impact on therapeutic applications.

Latest Patents

Fercej-Temeljotov's latest patents include innovative processes for the preparation of inclusion complexes of racemic ibuproxam and clavulanic acid. One of his notable inventions describes a new method for producing alkali clavulanate from an aqueous solution of crude clavulanic acid. This process involves the extraction of clavulanic acid using a hydrophobic β-CD derivative, resulting in novel inclusion complexes that are valuable in the treatment of infectious diseases. These complexes can be combined with amoxicillin trihydrate to create effective medicaments.

Career Highlights

Throughout his career, Fercej-Temeljotov has worked with prominent companies in the pharmaceutical industry, including Lek and Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d. in Ljubljana. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Fercej-Temeljotov has collaborated with several professionals in his field, including Janko Zmitek and Sonja Kotnik, who have contributed to his research and development efforts.

Conclusion

Darja Fercej-Temeljotov's innovative work in the pharmaceutical sector has led to the development of important therapeutic solutions. His patents and collaborations reflect his commitment to advancing medical science and improving patient care.